Neopharma - A world class pharmaceutical manufacturing facility in United Arab Emirates

News Room

Updated on: 28/Apr/2012
Public Awareness Campaign
Read more..

Updated on: 31/Mar/2009
Dr. B. R. Shetty, MD & CEO of NMC Group received the Padmashri Award from Smt. Pratibha Devisingh Patil, President of India
Read more..

Updated on: 9/Oct/2008
Introducing world-class pharmaceutical biotech products, to the United Arab Emirates
Read more..

Updated on: 10/Jan/2007
Dr. B R Shetty, received the award from the Indian President A.P.J Abdul Kalam
Read more..

Updated on: 5/Jan/2007
NMC Group to set up facility at DuBiotech
Read more..

Updated on: 4/Jan/2007
Dr. B R Shetty's Research Centre in Joint venture with India's Biocon
Read more..

Updated on: 3/Jan/2007
New version of drug for diabetics.
Read more..

Updated on: 22/Apr/2006
Neopharma launches its four new products.
Read more..

Updated on: 17/Apr/2006
NMC has donated life saving medicines amounting to Dh 1.3 million for the victims of Israeli aggression on Lebanon.
Read more..

Updated on: 11/Apr/2006
Neopharma, is all set to introduce 8 new brands in the domestic market.
Read more..

Updated on: 10/Nov/2005
The Abu Dhabi based pharmaceutical manufacturer, Neopharma has expanded its product range to include 5 new brands.
Read more..

Updated on: 20/Oct/2005
NMC Group and Neopharma rush aid to quake victims.
Read more..

Updated on: 20/Sep/2005
Neopharma starts exports to Yemen
Read more..

Updated on: 16/May/2005
Neopharma facility obtains GCC company registration certificate
Read more..

Updated on: 20/May/2005
Neopharma receives European GMP certificate
Read more..

2011

Neopharma receives UAE approval for Gliclazide sustained release tablets.
Neopharma makes its foray into CIS Markets with product launches in Tajikistan.
Neopharma introduces generic version of anti-diarrheal drug Loperamide in UAE.
Neopharma begins marketing of its first injectable product “Advacef”.
Neopharma launches generic version of Ivy Leaf extract Syrup.
Neopharma receives approval for the launch of generic version of Gliclazide Modified Release Tablets.
Neopharma receives approval for the launch of Urinary Alkalinizer, Fluconazole tablets and low osmolarity formula of Oral Rehydration Salts
Neopharma further expands operations in the African Market by starting the registration process in Ethiopia and Tanzania.
Registration of first set of products completed in Turkmenistan.
The UAE Genetic Diseases Association and Neopharma have joined hands for introducing Manal. The launch of Manal will form an integral part of the UAE GDA vision to prevent neural tube defects in the United Arab Emirates by Health Education, Public Awareness and Folic Acid Supplementation targeted for specific population.

2010

Neopharma has received the Certificate of EHS approval from the Abu Dhabi Emirate, Environment, Health and Safety Management System.

2009

Products are introduced into one of the biggest markets in the region – Saudi Arabia
Neopharma starts Kuwait operations
Neopharma moves into horizontal integration mode. Ground breaking ceremony heralds the start of new manufacturing facilities.

2008

Neopharma starts operations in the Sultanate of Oman.
Neopharma becomes the first pharmaceutical company in the region to obtain the integrated management system encompassing ISO 9001, ISO 14001 & OHSAS 18001.
Contract manufacturing for Lagap, Switzerland
Neopharma enters the Qatar pharmaceutical market
The first exports to East Africa commences with dispatch to Kenya
Neopharma enters the Afghanistan markets

2007

Neopharma and Biocon sign a joint venture, heralding the region’s first biotechnology company – Neobiocon.

More updates...